Table 4 Baseline Characteristics by Intravenous Atenolol Use and Time of Death
|
Intravenous Atenolol, Lived <48 H (n = 328)
|
Intravenous Atenolol, Lived >48 H (n = 17,711)
|
No Intravenous Atenolol, Lived <48 H (n = 1129)
|
|
| Age (yr) |
71 (63, 78) |
59 (50, 68) |
72 (64, 78) |
| Systolic blood pressure (mm Hg) |
130 (110, 145) |
130 (118, 148) |
110 (99, 130) |
| Heart rate, median (beats/min) |
82 (70, 97) |
76 (66, 88) |
81 (65, 100) |
| Killip class |
|
|
|
| I or II |
93.6 |
99.3 |
81.5 |
| III or IV |
6.4 |
0.7 |
18.5 |
| Location of infarction |
|
|
|
| Anterior |
59.5 |
43.3 |
55.9 |
Inferior
|
35.4
|
53.1
|
40.6
|
|
Data presented are percent of patients or median (25th, 75th percentiles).
|
